Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Blind, Randomised, Multi-centre, Active Controlled, Trial To Evaluate Safety, Tolerability, Pharmacokinetics And Efficacy Of Ceftazidime And Avibactam Compared With Cefepime In Children From 3 Months To Less Than 18 Years Of Age With Complicated Urinary Tract Infections (Cutis)

NCT02497781 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT02497781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02497781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Blind, Randomised, Multi-centre, Active Controlled, Trial To Evaluate Safety, Tolerability, Pharmacokinetics And Efficacy Of Ceftazidime And Avibactam Compared With Cefepime In Children From 3 Months To Less Than 18 Years Of Age With Complicated Urinary Tract Infections (Cutis)
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Completed
Start date
September 24, 2015
Completion date
September 15, 2017
Enrollment
97 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

complicated urinary tract infections